Variant report

Variant	rs9296190
Chromosome Location	chr6:36547448-36547449
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:9)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:36522642..36525654-chr6:36546165..36549998,4	MCF-7	breast:
2	chr6:36543022..36549115-chr6:36560475..36565724,11	K562	blood:
3	chr6:36409367..36412337-chr6:36545232..36548992,4	MCF-7	breast:
4	chr6:36546247..36549201-chr6:36553046..36554863,2	K562	blood:
5	chr6:36541858..36549149-chr6:36558071..36568608,24	MCF-7	breast:
6	chr6:36546135..36548821-chr6:36719778..36721832,2	MCF-7	breast:
7	chr6:36513307..36516814-chr6:36543552..36549139,6	MCF-7	breast:
8	chr6:36528875..36531304-chr6:36546279..36549068,3	MCF-7	breast:
9	chr6:36513376..36516513-chr6:36543508..36548000,7	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000112079	Chromatin interaction
ENSG00000112081	Chromatin interaction
ENSG00000179165	Chromatin interaction
ENSG00000112078	Chromatin interaction

Extended variants
information (count: 37 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:36)

rs_ID	r²[population]
rs1617092	0.93[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs1794623	0.81[AFR][1000 genomes]
rs596907	1.00[YRI][hapmap]
rs605925	0.91[AFR][1000 genomes]
rs606781	0.91[AFR][1000 genomes]
rs607735	0.88[AFR][1000 genomes]
rs609933	0.90[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs614001	1.00[YRI][hapmap];0.88[AFR][1000 genomes]
rs622171	0.93[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs638411	0.93[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs643877	0.93[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs644634	0.86[AFR][1000 genomes]
rs646501	0.93[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs651070	0.93[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs651144	1.00[YRI][hapmap];0.93[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs651553	1.00[YRI][hapmap];0.93[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs652896	0.84[AFR][1000 genomes]
rs655573	0.84[AFR][1000 genomes]
rs656049	0.88[AFR][1000 genomes]
rs668460	0.88[AFR][1000 genomes]
rs669779	1.00[YRI][hapmap];0.88[AFR][1000 genomes]
rs674713	0.90[AFR][1000 genomes]
rs675619	0.91[AFR][1000 genomes]
rs682937	0.88[AFR][1000 genomes]
rs685109	1.00[YRI][hapmap];0.91[AFR][1000 genomes]
rs685997	0.91[AFR][1000 genomes]
rs686057	0.91[AFR][1000 genomes]
rs686478	0.91[AFR][1000 genomes]
rs7774108	0.82[YRI][hapmap]
rs9296189	0.85[YRI][hapmap];0.82[AFR][1000 genomes]
rs9462199	0.80[YRI][hapmap]
rs9470327	0.90[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs9470328	0.93[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs9470329	0.90[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs9470331	1.00[YRI][hapmap];0.93[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs9470332	0.93[AFR][1000 genomes];1.00[AMR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:1 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv885806	chr6:36349890-36621178	Flanking Bivalent TSS/Enh Strong transcription Weak transcription Enhancers Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	103 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:80 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:36535200-36551200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr6:36540000-36547800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr6:36544000-36548000	Enhancers	Placenta	Placenta
4	chr6:36544200-36548400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
5	chr6:36544400-36548200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
6	chr6:36544400-36548200	Enhancers	Muscle Satellite Cultured Cells	--
7	chr6:36544600-36548200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
8	chr6:36544600-36548200	Enhancers	Fetal Intestine Small	intestine
9	chr6:36544800-36548000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
10	chr6:36545000-36548000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
11	chr6:36545000-36548000	Enhancers	NH-A	brain
12	chr6:36545000-36548400	Enhancers	Breast Myoepithelial Primary Cells	Breast
13	chr6:36545200-36547600	Enhancers	Rectal Smooth Muscle	rectum
14	chr6:36545200-36548200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
15	chr6:36545800-36548400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
16	chr6:36546200-36547600	Weak transcription	Esophagus	oesophagus
17	chr6:36546200-36547600	Weak transcription	NHDF-Ad	bronchial
18	chr6:36546200-36548000	Enhancers	HSMM	muscle
19	chr6:36546400-36547600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
20	chr6:36546400-36547600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
21	chr6:36546400-36547600	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
22	chr6:36546400-36547600	Weak transcription	Aorta	Aorta
23	chr6:36546400-36547800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
24	chr6:36546400-36548000	Enhancers	Duodenum Smooth Muscle	Duodenum
25	chr6:36546400-36548400	Enhancers	Primary monocytes fromperipheralblood	blood
26	chr6:36546600-36547600	Weak transcription	Gastric	stomach
27	chr6:36546800-36548200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
28	chr6:36546800-36548200	Enhancers	Primary B cells from cord blood	blood
29	chr6:36547000-36548000	Enhancers	Fetal Intestine Large	intestine
30	chr6:36547000-36548000	Enhancers	Fetal Thymus	thymus
31	chr6:36547000-36548200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
32	chr6:36547200-36547600	Enhancers	Adipose Nuclei	Adipose
33	chr6:36547200-36547600	Weak transcription	Fetal Stomach	stomach
34	chr6:36547200-36547600	Enhancers	K562	blood
35	chr6:36547200-36548000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
36	chr6:36547200-36548000	Enhancers	Primary hematopoietic stem cells	blood
37	chr6:36547200-36548000	Enhancers	NHEK	skin
38	chr6:36547200-36548200	Enhancers	Fetal Heart	heart
39	chr6:36547200-36548200	Enhancers	Fetal Muscle Leg	muscle
40	chr6:36547200-36548200	Enhancers	Stomach Mucosa	stomach
41	chr6:36547200-36548200	Enhancers	HMEC	breast
42	chr6:36547400-36547600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
43	chr6:36547400-36547600	Active TSS	Stomach Smooth Muscle	stomach
44	chr6:36547400-36547800	Enhancers	ES-I3 Cell Line	embryonic stem cell
45	chr6:36547400-36547800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
46	chr6:36547400-36547800	Enhancers	HUES48 Cell Line	embryonic stem cell
47	chr6:36547400-36547800	Flanking Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
48	chr6:36547400-36547800	Enhancers	iPS-15b Cell Line	embryonic stem cell
49	chr6:36547400-36547800	Enhancers	Primary T helper cells fromperipheralblood	blood
50	chr6:36547400-36547800	Enhancers	Primary T killer naive cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links